[Somerset, NJ, Aug 15, 2023] – WhizAI, the leading provider of a generative AI-powered analytics platform for the life sciences and healthcare industries, today announced its inclusion in the prestigious Inc. 5000 list of America's fastest-growing private companies for 2023. The Inc. 5000 list, published annually by Inc. magazine, celebrates entrepreneurial success by identifying and honoring the top 5000 privately held companies in the United States. WhizAI's inclusion at No. 467 on this exclusive list underscores its rapid growth, innovation, and dedication to transforming the life sciences through the power of generative AI.
WhizAI has experienced remarkable expansion since its inception, driven by its cutting-edge generative AI platform that leverages natural language processing and machine learning to automate data analysis and business insight generation. This technology empowers life sciences and healthcare organizations to derive actionable insights from vast amounts of data, enhancing decision-making, operational efficiency, and patient outcomes.
"We are thrilled and honored to be recognized on the Inc. 5000 list," said Rohit Vashisht, Co-founder and CEO, WhizAI. "This achievement is a testament to the hard work and commitment of our talented team and the transformative solutions we provide to our clients in pharma. By harnessing the power of generative AI and advanced analytics, we are revolutionizing the way life sciences and healthcare organizations leverage data to drive better outcomes and improve patient care.
WhizAI's innovative analytics platform has been widely adopted by large and mid-sized commercial pharma organizations seeking to unlock the true value of their data assets. By automating data analysis processes and generating dashboards on the fly using generative AI, WhizAI enables users to swiftly uncover critical insights, identify trends, and streamline decision-making across various domains, including field sales, patient claims, patient services, payer and market access analytics, and more.
As an Inc. 5000 honoree, WhizAI joins an elite group of rapidly growing and influential companies that have achieved outstanding success in the competitive landscape of the American business world. The recognition not only showcases WhizAI's dedication to excellence but also reaffirms its commitment to driving innovation and advancing the use of artificial intelligence in healthcare.
WhizAI is the first and only generative AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users, empowering decision-makers to drive more informed and faster business decisions at a lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with self-service analytics, zero-code dynamic dashboarding, and automated insights generation, making WhizAI the trusted partner of choice at top global pharma and healthcare companies. Learn more at whiz.ai.
More about Inc. and the Inc. 5000
Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and be generating revenue by March 31, 2019. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2019 is $100,000; the minimum required revenue for 2022 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. The entire Inc. 5000 can be found at http://www.inc.com/inc5000.
The world’s most trusted business-media brand, Inc., offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches over 50 million people each month across various channels, including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced annually since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference & Gala is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.
For media inquiries, please contact:
Name: Richard Clements
People also viewed
A New Era of Personalization: Applying Generative AI to Dynamic Customer Engagement
Webinar Series: Part 4 - Give Your Life Sciences Analytics the ExplAIn Advantage
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers the total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.